Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Valves

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...

Anatomy of the Heart

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insights Into the Revision of Heart Transplant Allocation Criteria　- Analysis of Waitlist Mortality and Transplant Probability for Adult Heart Transplant Candidates in the Nationwide Registry Data of Japan.

Circulation journal : official journal of the Japanese Circulation Society·2026

Same author

Efficacy and Safety of First-Line Ramucirumab Plus Erlotinib for <i>EGFR</i> L858R-Mutated NSCLC in Real-World Practice: A Retrospective Multicenter REAL-SPEED Analysis.

JTO clinical and research reports·2026

Same author

Arbitrary polarization control with a segmented APPLE-II undulator.

Journal of synchrotron radiation·2025

Same author

Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan.

Investigational new drugs·2025

Same author

Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring <i>EGFR</i> Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).

Therapeutic advances in medical oncology·2025

Same author

The Ragulator complex and lysosomal calcium release are crucial for cell migration.

Life science alliance·2025

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

[Artificial heart].

Takeshi Nakatani¹

¹Department of Organ Transplantation, National Cardiovascular Center, Suita, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery

|May 23, 2007

Summary

Advanced artificial heart devices, including ventricular assist systems (VAS), offer life-saving support for profound heart failure. Ongoing innovations focus on smaller, implantable devices for improved patient outcomes and treatment options.

Area of Science:

Cardiovascular Engineering
Medical Device Development
Heart Failure Management

Context:

Profound heart failure necessitates advanced interventions like artificial hearts or transplantation.
Ventricular assist systems (VAS) have evolved significantly since the 1950s, with Japanese models introduced in the 1980s.
Over 850 patients have utilized various VAS, with 80% of heart transplant recipients benefiting from them for an average of 714 days.

Purpose:

To review the development and clinical application of artificial heart technologies, focusing on ventricular assist systems (VAS).
To highlight the need for smaller, implantable left ventricular assist devices (LVAS).
To discuss the current status and future directions of artificial heart and transplantation therapies for end-stage heart failure.

Summary:

More Related Videos

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Related Experiment Videos

Last Updated: Jul 14, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Artificial heart and ventricular assist system (VAS) technologies have progressed substantially, aiding over 850 patients and supporting 80% of heart transplant recipients.
Current research focuses on developing small, implantable left ventricular assist devices (LVAS), including non-pulsatile pumps and Japanese centrifugal pumps.
Destination therapy using implantable pulsatile LVAS is now available for end-stage heart failure in the US and Europe.

Impact:

Ventricular assist systems (VAS) significantly improve survival and quality of life for patients with end-stage heart failure.
Advancements in artificial heart technology, particularly implantable LVAS, expand treatment options beyond transplantation.
Future selection between artificial hearts and transplantation will be tailored to individual patient conditions for optimal outcomes.